ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,310,000 | -7.8% | 40,000 | -7.0% | 0.44% | -10.8% |
| Q2 2020 | $7,925,000 | -14.6% | 43,000 | -6.5% | 0.49% | -21.9% |
| Q1 2020 | $9,281,000 | -27.1% | 46,000 | -32.4% | 0.63% | +5.0% |
| Q4 2019 | $12,724,000 | +17.2% | 68,000 | 0.0% | 0.60% | +25.7% |
| Q3 2019 | $10,853,000 | -49.3% | 68,000 | -20.0% | 0.48% | -42.8% |
| Q2 2019 | $21,412,000 | -0.6% | 85,000 | -5.6% | 0.84% | -7.6% |
| Q1 2019 | $21,540,000 | +3.7% | 90,000 | -0.5% | 0.90% | -13.9% |
| Q4 2018 | $20,769,000 | -20.3% | 90,452 | -1.9% | 1.05% | +10.7% |
| Q3 2018 | $26,072,000 | -7.6% | 92,207 | -4.1% | 0.95% | -3.4% |
| Q2 2018 | $28,229,000 | +1.7% | 96,131 | -12.6% | 0.98% | +0.2% |
| Q1 2018 | $27,764,000 | -3.4% | 110,000 | -17.3% | 0.98% | +11.2% |
| Q4 2017 | $28,728,000 | -0.3% | 133,000 | -14.2% | 0.88% | -27.5% |
| Q3 2017 | $28,807,000 | -4.6% | 155,000 | -11.4% | 1.22% | +173.0% |
| Q2 2017 | $30,188,000 | -5.2% | 175,000 | -16.1% | 0.44% | -11.5% |
| Q1 2017 | $31,853,000 | +3.6% | 208,600 | 0.0% | 0.50% | -6.7% |
| Q4 2016 | $30,737,000 | -4.6% | 208,600 | -18.2% | 0.54% | -4.8% |
| Q3 2016 | $32,215,000 | -7.8% | 255,000 | -17.7% | 0.57% | +4.4% |
| Q2 2016 | $34,953,000 | -1.2% | 310,000 | -8.8% | 0.54% | -8.0% |
| Q1 2016 | $35,392,000 | -7.7% | 340,000 | 0.0% | 0.59% | -1.3% |
| Q4 2015 | $38,345,000 | -0.8% | 340,000 | -3.7% | 0.60% | -10.1% |
| Q3 2015 | $38,636,000 | -10.2% | 353,000 | -21.6% | 0.66% | +6.6% |
| Q2 2015 | $43,043,000 | +2.7% | 450,000 | 0.0% | 0.62% | -0.6% |
| Q1 2015 | $41,902,000 | +13.7% | 450,000 | 0.0% | 0.63% | +13.8% |
| Q4 2014 | $36,869,000 | +27.6% | 450,000 | 0.0% | 0.55% | +31.2% |
| Q3 2014 | $28,883,000 | +4.5% | 450,000 | -1.0% | 0.42% | +0.2% |
| Q2 2014 | $27,644,000 | +31.0% | 454,600 | +29.0% | 0.42% | +23.6% |
| Q1 2014 | $21,095,000 | +9.6% | 352,500 | +16.6% | 0.34% | +0.9% |
| Q4 2013 | $19,254,000 | +13.4% | 302,400 | +21.0% | 0.34% | +5.7% |
| Q3 2013 | $16,975,000 | -5.9% | 250,000 | 0.0% | 0.32% | -19.3% |
| Q2 2013 | $18,035,000 | – | 250,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |